Chg IV Dressing with Chlorhexidine for Central Line Infection Prevention

Name: Chg IV Dressing with Chlorhexidine for Central Line Infection Prevention
Brand: Weifang Hota New Material Technology Co., Ltd.
SKU: 1935391645

Shandong, ChinaWeifang Hota New Material Technology Co., Ltd.

US$0.50

1-499 Pieces

US$0.40

500+ Pieces

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Customized

Certification

ISO

Model NO.

HT007

Feature

Type

Product Name

Chg IV Dressing

Active Ingredient

Chlorhexidine Gluconate (Chg)

Material

Transparent PU Film + Chg Gel Pad

Mask Type

Safe-Type

Disposable / Reusable

Disposable

Type 1

Antimicrobial IV Catheter Dressing

Usage

Outdoor Face Mask

Layer

5 Plys

Sterile / Non-Sterile

Sterile

Color

Transparent

Size

Standard Size / Customized Sizes Available

Shape

Square / Oval

Breathability

Breathable, Moisture Vapor Permeable

Waterproof

Yes

Latex-Free

Yes

Transport Package

20PCS/Box

Specification

160x110mm

Trademark

Hota

Origin

China

HS Code

63079000

Production Capacity

99999999999PCS/Day

Company profile

Self-brandedExhibition ExperienceR&D CapabilitiesProduct Certification

Weifang Hota New Material Technology Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Group CorporationExport Year: 2016-02-21Nearest Port: qingdao port, shanghai port, beijing airportAverage Response Time: ≤2.63hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW

AI-Powered supplier vetting

SummaryWeifang Hota New Material Technology Co., Ltd. is identified as a China-based manufacturer/factory and limited company with 21 employees, offering a broad range of medical disposable products. It demonstrates customization, ODM, and OEM capabilities and has participated in the CMEF trade show. The supplier reports CE certification and regular fire drills, but lacks an environmental impact assessment report. Service capability is supported by 10 qualified suppliers, although supplier assessment and corrective-action procedures lack written records, and complaint handling has procedures without written records. Innovation evidence is limited: no new products were introduced in the past year, and no 3D software or SDK capability is available. Overseas service infrastructure is absent, with no overseas warehouses, showrooms, agents, or branches. An audit by BV is recorded with validity from 2026-05-27 to 2027-05-26, but the stated audit evaluation result is 0.

Supplier typeThe supplier is explicitly identified as a manufacturer/factory and limited company based in Weifang, Shandong, China. Its stated product scope covers multiple medical disposable categories, and the audit record identifies the same broad product portfolio.

CertificationsThe supplier reports CE certification and has a BV audit record valid from 2026-05-27 to 2027-05-26. However, the stated audit evaluation result is 0, and no additional certification details are provided.

Production capacityThe supplier is explicitly classified as a manufacturer/factory and offers a broad portfolio of medical disposable products. The audit record covers this product scope, but the slices do not provide production capacity, equipment, output, or quality-performance measurements.

Customization capabilityThe supplier explicitly provides customization from samples, designs, full customization, minor customization, and flexible customization. It also offers ODM and OEM services for popular brands, providing direct evidence of broad customization capability.